Longxuetongluo Capsule Inhibits Atherosclerosis Progression in High-Fat Diet-Induced ApoE-/- Mice by Improving Endothelial Dysfunction.

Jiao Zheng,Binglin Liu,Qixing Lun,Xiaopan Gu,Bo Pan,Yunfang Zhao,Wei Xiao,Jun Li,Pengfei Tu
DOI: https://doi.org/10.1016/j.atherosclerosis.2016.08.022
IF: 5.3
2016-01-01
Atherosclerosis
Abstract:Background and aims: Chinese dragon's blood has been used to treat blood stasis for thousands of years. Its total phenolic extract (Longxuetongluo capsule, LTC) is used for the treatment of ischemic stroke; however, its protective effect against atherosclerosis remains poorly understood. This paper aims to investigate the antiatherosclerotic effect of LTC and the underlying mechanisms in high-fat diet (HFD)induced ApoE(-/-) mice.Methods: The levels of plasma lipid and areas of atherosclerotic lesions in the aortic sinus in ApoE(-/-) mice were evaluated. The effect of LTC on the nitric oxide (NO) production in oxidized low-density lipoprotein (ox-LDL)-stimulated human umbilical vein endothelial cells (HUVECs) was determined. The adhesion of monocytes to ox-LDL-stimulated HUVECs was further studied.Results: LTC at low, medium, and high doses markedly decreased the atherosclerotic lesion areas of the aortic sinus in HFD-induced ApoE(-/-) mice by 26.4% (p < 0.05), 30.1% (p < 0.05), and 46.5% (p < 0.01), respectively, although it did not improve the dyslipidemia. Furthermore, LTC restored the diminished NO production of ox-LDL-stimulated HUVECs (p < 0.001) and inhibited the adhesion between monocytes and endothelial cells (p < 0.01). LTC appeared to alleviate ox-LDL-stimulated dysfunction of HUVECs, and inhibit the adhesion of monocytes to HUVECs via the MAPK/IKK/IkB/NF-kappa B signaling pathway, thus decrease atherosclerotic lesions in the aortic sinus in HFD-induced ApoE(-/-) mice.Conclusions: These findings suggest the potential of LTC for use as an effective agent against atherosclerosis. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
What problem does this paper attempt to address?